NYSE$TIC
Acuren Corp · Q3 2025 earnings
Q3 2025 earnings ·
Briefing
TIC reported Q3 2025 revenue of €473.9M, a net loss of €13.9M, diluted EPS of $0.08.
For Q3 2025, TIC reported Revenue was €473.9M, net loss was €13.9M, diluted EPS was $0.08. The filing discusses operating performance, liquidity, and outlook in MD&A.
- Revenue €473.9M for Q3 2025.
- Net loss €13.9M.
- Diluted EPS $0.08.
Headline financials
Revenue & EPS history
Acuren Corp · Revenue · Quarterly
$474M
Forward guidance
Outlook focuses on cash runway, pipeline milestones, and cost discipline as the company works toward profitability.
Tailwinds
- Cash and equivalents support operations into upcoming milestones.
- Clinical or product pipeline progress noted in MD&A.
Headwinds
- Ongoing operating losses and R&D spend pressure near-term earnings.
- Financing, dilution, or partnership timing may affect liquidity.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 4 quarterly earnings reports · overlaid with Q3 2025
-0.1%
Avg return
Earnings day
-1.9%
Avg return
5 days after
+1.7%
Avg return
30 days after
25%
1 / 4 earnings
Positive
+8.5%
Q1 2026
Best reaction
-4.2%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +8.5% | +2.2% | -11.9% | |
| Q3 2025 | -4.2% | -17.1% | -5.2% | |
| Q2 2025 | -1.4% | +3.4% | +18.3% | |
| Q1 2025 | -3.4% | +3.9% | +5.7% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro